Hospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (75)

2024

  1. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

2023

  1. Pyogenic liver abscesses in liver transplant recipients versus non-transplant population. Outcome and risk factors of patient survival

    Clinical Transplantation, Vol. 37, Núm. 6

  2. Risk factors indicating the need for surgical therapy in patients with pyogenic liver abscesses

    Langenbeck's Archives of Surgery, Vol. 408, Núm. 1

  3. Risk factors of massive blood transfusion in liver transplantation: consequences and a new index for prediction including the donor

    Cirugia Espanola, Vol. 101, Núm. 10, pp. 684-692

2022

  1. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

  2. Liver Transplantation in Sexagenarian Patients Using Grafts From Uncontrolled Circulatory Death Versus Grafts From Brain Death Donation

    Transplantation Proceedings, Vol. 54, Núm. 7, pp. 1839-1846

  3. Modifications in Abdominal Wall Graft Retrieval: When the Donor Closure Is Not Guaranteed

    Transplantation Proceedings, Vol. 54, Núm. 9, pp. 2422-2426

  4. New technique for abdominal wall procurement. Initial experience

    Clinical Transplantation, Vol. 36, Núm. 2

  5. Short series regarding uncontrolled donor after cardiac death: A call for caution

    Clinical Transplantation

2021

  1. Authors’ response to Cai et al. on their commentary on “Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals” (Int J Surg 2021, 106096)

    International Journal of Surgery

  2. Cystic liver neoplams: A single centre experience and literature review

    Cirugia Espanola, Vol. 99, Núm. 1, pp. 27-33

  3. Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single-Center Prospective Study

    Liver Transplantation, Vol. 27, Núm. 6, pp. 913-917

  4. Hemoderivative Transfusion in Liver Transplantation: Comparison Between Recipients of Grafts From Brain Death Donors and Recipients of Uncontrolled Donors After Circulatory Death

    Transplantation Proceedings, Vol. 53, Núm. 7, pp. 2298-2304

  5. Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation

    Scientific Reports, Vol. 11, Núm. 1

  6. Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals. Retrospective cohort study

    International Journal of Surgery, Vol. 91

  7. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794

  8. Validation of McCluskey Index for Massive Blood Transfusion Prediction in Liver Transplantation

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2698-2701

2020

  1. Biliary Complications After Liver Transplantation From Uncontrolled Donors After Circulatory Death: Incidence, Management, and Outcome

    Liver Transplantation, Vol. 26, Núm. 1, pp. 80-91

  2. Fistulo-jejunostomy as an alternative treatment in the repair of a complex biliary leak

    Cirugia Espanola, Vol. 98, Núm. 3, pp. 166-168

  3. Use of Nonvascularized Fascia in Liver Transplantation

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1468-1471